- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Ophthalmological Medicine
Volume 2013 (2013), Article ID 579121, 3 pages
Full-Thickness Eyelid Lesions in Sarcoidosis
1Department of Ophthalmology, University of Wisconsin, Madison, WI, USA
2Section of Dermatology, University of Chicago, Chicago, IL, USA
3Section of Rheumatology, University of Illinois, Chicago, IL, USA
4Department of Ophthalmology, University of Hong Kong, Cyberport, Hong Kong
Received 10 March 2013; Accepted 17 April 2013
Academic Editors: N. Fuse, M. Rosner, and S. Schwartz
Copyright © 2013 Megan E. Collins et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Eyelid involvement in sarcoidosis is very rare. A search of the medical literature indicates one previous report of sarcoidosis with destructive eyelid lesions. We describe the case of a 50-year-old woman with severe systemic sarcoidosis, which included her eyelids. To our knowledge, the case presented herein represents the first to show the full-thickness histopathology of destructive eyelid lesions in sarcoidosis.
Sarcoidosis is a multisystem inflammatory disease of unknown etiology characterized histopathologically by noncaseating granulomas. The condition has a female predilection with a peak incidence in the 3rd and 5th decades of life. Pulmonary involvement is the most common manifestation. Common extrapulmonary manifestations include the skin, central nervous system, liver, kidney, and musculoskeletal system. Furthermore, sarcoidosis can affect the heart, peripheral nervous system, salivary glands, eye, and ocular adnexa. Ocular involvement occurs in 25%–60% of patients with systemic sarcoidosis [1, 2]. While the disease can involve any ocular tissue, anterior uveitis and lacrimal gland involvement are the most frequently reported findings . Eyelid manifestations of sarcoidosis include “millet seed” nodules, ulcerated nodules, plaques, and swollen eyelids . Eyelid involvement in sarcoidosis is very rare. To our knowledge, there is only one previous report in the literature that describes full-thickness eyelid involvement. Our case is the first to show the full-thickness histopathology of destructive eyelid lesions in sarcoidosis.
2. Case Report
A 50-year-old female with severe systemic sarcoidosis, including pulmonary, skin, and joint disease, presented for evaluation of ocular involvement. The patient had noted eyelid nodules for over 5 years; however, she recently developed eyelid deformities, tearing, and eye irritation.
On examination, she had notching of her upper and lower eyelids and extensive scarring of the posterior lamella leading to entropion and focal trichiasis (Figure 1). Slit lamp examination showed complete inspissation of the meibomian glands and superficial keratitis corresponding with misdirected eyelashes. The remainder of the anterior and posterior segment examination was within normal limits. Medical therapy did not adequately control the patient’s symptoms.
The patient subsequently underwent full-thickness wedge resections in both upper eyelids and her right lower eyelid resulting in symptomatic improvement and elimination of the localized areas of trichiasis. Histopathologic evaluation of all three full-thickness wedge resections showed typical “naked,” noncaseating granulomas composed of epitheliod histiocytes and multinucleated giant cells (Figure 2). Serial sections showed extensive destruction of both the anterior and posterior lamellar anatomies, including derangement of the tarsal architecture, obliteration of the meibomian glands, and infiltration of the dermis and orbicularis oculi muscle. Entropic migration of the mucocutaneous junction and eyelash misdirection were also seen. Ziehl-Neelsen and Gomori’s methenamine silver stains were negative for microorganisms.
Early reports have limited discussion of the incidence of eyelid involvement in sarcoidosis [3, 5]. Eyelid manifestations of sarcoidosis include “millet seed” nodules, ulcerated nodules, plaques, and swollen eyelids . In 1986, Jabs and Johns described eyelid nodules in 5/183 patients (0.27%) with systemic sarcoidosis ; however, a 2007 review of 26 patients with sarcoidosis and orbital disease found eyelid involvement in 11.5% of patients . The actual incidence of eyelid involvement remains uncertain. In addition, limited data has been published on the correlation of eyelid involvement and disease severity. For example, our patient had severe systemic sarcoidosis resistant to aggressive immunosuppressive and immunomodulating therapy.
A Pubmed literature search (http://www.ncbi.nlm.nih.gov/pubmed/, accessed 10 March 2013) of “eyelid and sarcoid” indicates one previous case  of involvement of both the anterior and posterior lamellae of the eyelids. In 2001 Moin et al. first described destructive full-thickness sarcoidosis lesions of the eyelids . The authors showed a high magnification image of a small segment of tissue; however, an oriented figure with the full-thickness microscopic anatomy of the eyelid was absent . To our knowledge, a full-thickness histologic depiction of an eyelid showing destructive lesions in sarcoidosis has not been previously published. In addition, the complete obliteration of the eyelid meibomian glands by the sarcoidosis granulomatous infiltrates seen in our case represents new findings. Dry eyes in patients with sarcoidosis are often attributed to sarcoid infiltration of the lacrimal gland. Based on our findings, sarcoid destruction of the meibomian glands may represent an additional etiology for dry eyes in sarcoidosis patients with eyelid involvement.
Conflict of Interests
The authors have no financial or proprietary conflicts of interests in the material presented.
- D. A. Jabs and C. J. Johns, “Ocular involvement in chronic sarcoidosis,” American Journal of Ophthalmology, vol. 102, no. 3, pp. 297–301, 1986.
- V. C. Prabhakaran, P. Saeed, B. Esmaeli et al., “Orbital and adnexal sarcoidosis,” Archives of Ophthalmology, vol. 125, no. 12, pp. 1657–1662, 2007.
- C. D. Obenauf, H. E. Shaw, C. F. Sydnor, and G. K. Klintworth, “Sarcoidosis and its ophthalmic manifestations,” American Journal of Ophthalmology, vol. 86, no. 5, pp. 648–655, 1978.
- S. Brownstein, A. D. Liszauer, W. D. Carey, and D. A. Nicolle, “Sarcoidosis of the eyelid skin,” Canadian Journal of Ophthalmology, vol. 25, no. 5, pp. 256–259, 1990.
- J. G. Hall and K. L. Cohen, “Sarcoidosis of the eyelid skin,” American Journal of Ophthalmology, vol. 119, no. 1, pp. 100–101, 1995.
- M. Moin, R. C. Kersten, F. Bernardini, and D. R. Kulwin, “Destructive eyelid lesions in sarcoidosis,” Ophthalmic Plastic and Reconstructive Surgery, vol. 17, no. 2, pp. 123–125, 2001.